GSK Investigational Site

Sankt Gallen 9007

0 studies enrolling now · 6 studies all time

What they study most

Asthma, HIV Infection, Infection, Human Immunodeficiency Virus, Neoplasms, Head and Neck, Systemic Lupus Erythematosus, Vasculitis

Studies at this site

• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Belimumab (BENLYSTA®) Pregnancy Registry — Completed
• Belimumab Assessment of Safety in SLE — Completed
• Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Stopped early
• Belimumab in Remission of VASculitis — Completed
• KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks — Completed